Transcription factors as critical players in melanoma invasiveness, drug resistance, and opportunities for therapeutic drug development
Open Access
- 1 November 2017
- journal article
- review article
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 31 (2) , 241-252
Abstract
Summary: Resistance to targeted therapy in cancer is often coupled with the acquisition of a pro‐invasive phenotype by tumors cells and a highly permissive tumor microenvironment promoting drug resistance. Transcription factors are frequently shown as major points of convergence of multiple dysregulated receptors and signaling pathways in cancer. Several transcription factors are now incriminated as drivers of both drug resistance and invasiveness. We focused this review on critical transcription factors playing a causal role in both the resistance to BRAF V600E‐targeted therapy and the pro‐invasive behavior of melanoma cells. Simultaneous rewiring of pro‐oncogenic signaling pathways, phenotype switching or phenotypic plasticity supporting pro‐invasive/pro‐metastatic behavior, actin remodeling, and bidirectional interactions between tumor microenvironment and melanoma cells represent major challenges for overcoming resistance to BRAF V600E inhibitors (BRAFi) and will be discussed. Although it represents an underdeveloped area of translational investigation, inhibition of transcription factors may open new avenues to combat resistance to BRAFi.Keywords
Funding Information
- American Cancer Society (116683‐RSG‐09‐087‐01‐TBE)
- National Cancer Institute (N01 CA10‐034)
This publication has 73 references indexed in Scilit:
- Heterogeneity of expression of epithelial–mesenchymal transition markers in melanocytes and melanoma cell linesFrontiers in Genetics, 2013
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretionNature, 2012
- MYC on the Path to CancerCell, 2012
- Human Cutaneous Melanomas Lacking MITF and Melanocyte Differentiation Antigens Express a Functional Axl Receptor KinaseJournal of Investigative Dermatology, 2011
- Adaptive upregulation of FOXD3 and resistance to PLX4032/4720-induced cell death in mutant B-RAF melanoma cellsOncogene, 2011
- Physical and functional interactions between Runx2 and HIF-1α induce vascular endothelial growth factor gene expressionJournal of Cellular Biochemistry, 2011
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensationTrends in Biochemical Sciences, 2011
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivationNature, 2010
- Selective inhibition of BET bromodomainsNature, 2010
- Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonistsProceedings of the National Academy of Sciences, 2007